Delta opioid extends hypothermic preservation time of the lung  by Wu, Guanghan et al.
DELTA OPIOID EXTENDS 
HYPOTHERMIC 
PRESERVATION TIME 
OF THE LUNG 
To test the hypothesis that a delta opioid, DADLE ([D-Ala z, D-LeuS]-en - 
kephalin), could protect tissue from ischemic damage during hypothermic lung 
preservation, we studied three groups of rats. In group 1 (n = 8), lung 
function was studied immediately after harvesting. In group 2 (n = 8), the 
lung was flushed with 4 ° C Euro-Collins solution and preserved for 24 
hours. In group 3 (n = 8), the lung was flushed with 4 ° C Euro-Collins 
solution plus DADLE (1 mg/kg) and preserved for 24 hours. Lung function 
was studied by using a living rat perfusion model. Venous blood from the 
host rat perfused the pulmonary artery of the isolated lung. Blood from the 
isolated lung was returned to the carotid artery of the host rat with a roller 
pump. Severe pulmonary edema, hemorrhage, and occlusive pulmonary 
artery resistance occurred in group 2 within 30 minutes of perfusion. 
Perfusion studies were carried out for more than 60 minutes in groups 1 
and 3. Pulmonary blood flow was lower in group 2 than in either group 1 or 
group 3. Pulmonary vascular esistance was much higher in group 2 than 
in groups 1 and 3 (p < 0.05). Airway pressure and airway resistanee were 
much higher in group 2 than in groups 1 and 3 (p < 0.05). Airway resistance 
was also higher in group 3 than in group 1 after 20 minutes of perfusion 
(p < 0.05). Oxygen tensions from the pulmonary vein of the isolated lung in 
group 2 were lower than those in groups 1 and 3 (p < 0.05). Alveolar- 
arterial oxygen difference was much higher in group 2 than in groups 1 and 
3 (p < 0.05). Lung tissue wet/dry weight ratio after perfusion was much 
higher in group 2 than in groups 1 and 3. The results clearly show, for the 
first time, that DADLE can effectively enhance hypothermic lung preser- 
vation in rats. (J THORAC CARDIOVASC SURG 1996;111:259-67) 
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D uring the past 30 years, various methods have 
been developed for preserving solid organs for 
transplantation. I  many cases, these methods have 
included flushing or perfusing organs with cold 
crystalloid solution or plasma. The recent develop- 
ment of the University of Wisconsin solution now 
permits kidneys to be stored for 72 hours and livers 
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for 24 hours in animal studies. However, safe clinical 
preservation times for the heart and lungs are still 
limited to 4 to 6 hours, no matter what solution is 
used (including University of Wisconsin solution, 
Euro-Collins solution, low-potassium dextran solu- 
tion, University of California-Los Angeles solution, 
and the above solutions with many additives). In our 
normothermic multiple organ preservation studies, 
we found that a delta opioid, DADLE ([D-Ala 2, 
D-LeuS]-enkephalin), could extend tissue survival 
time substantially. The principal mechanism by 
which DADLE extended tissue survival time was 
thought o be related to its ability to protect issue 
from ischemic damage in several aspectsJ Because 
of technical difficulties, normothermic multiple or- 
gan preparations are used by only a few groups 
around the world, 2' 3 and the use of DADLE in such 
preparations i limited at the present ime. To test 
the hypothesis that DADLE could also protect 
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tissue from ischemic damage during hypothermia,  
we per formed an isolated lung preservat ion study 
and found that DADLE could substantial ly enhance 
hypothermic lung preservation. This article reports 
the results of that study. 
Methods 
Adult Sprague-Dawley rats (250 to 300 gm) were al- 
lowed free access to food and water before operation. All 
animals received humane care in compliance with the 
"Principles of Laboratory Animal Care" formulated by 
the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). 
Preparation of hypothermic isolated lung storage. The 
rat was anesthetized by intraperitoneal injection of so- 
dium pentobarbital (50 to 55 mg/kg). The cervical trachea 
was cannulated, and the animal's lungs were ventilated 
with room air by means of a rodent respirator. Tidal 
volume of 2.5 to 3.5 ml, rate 40 to 50 rpm, and peak 
end-expiratory pressure of 0.5 cm H20 were maintained. 
The retrosternal space was exposed by blunt dissection, 
and two large straight clamps were applied in a parallel 
fashion across the sternum. Care was taken not to injure 
the lungs and vessels beneath. The chest was opened 
through a median sternotomy. After intravenous admin- 
istration of 1 mg heparin sodium, the inferior pulmonary 
ligaments were carefully divided. The left superior vena 
cava was divided and ligated. The hilum of the left lung 
was approached anteriorly, and the vessels and bronchus 
were separated by blunt dissection. The left pulmonary 
artery was dissected, and a suture was placed around it. 
The main pulmonary artery was transected through the 
transverse sinus, and a cannula was placed in the left 
pulmonary artery through the transected main pulmonary 
artery. The suture around the left pulmonary artery was 
tied, and the left atrium was partly excised for decom- 
pressing. The left lung was flushed with 4 ° C preservation 
solution until the lung was completely white. The lung was 
removed and preserved at 4 ° C for 24 hours before 
functional studies. 
Technique of isolated lung function studies. A perfu- 
sion apparatus consisting of a living host rat and a 
temperature-controlled, humidified chamber was used 
for isolated lung function studies. The host rat was 
anesthetized by intraperitoneal injection of sodium 
pentobarbital (50 to 55 mg/kg). The cervical trachea 
was cannulated, and the animal's lungs were ventilated 
with room air by a rodent respirator. Tidal volume of 
2.5 to 3.5 ml and rate of 40 to 50 rpm were maintained. 
The right internal jugular vein was cannulated with a 2 
mm catheter. Heparin sodium 3 mg/kg was infused 
intravenously, and both carotid arteries were cannu- 
lated with 1 mm catheters. The catheter in the right 
carotid artery was connected to a pressure transducer 
for arterial blood pressure monitoring. The host rat was 
placed above the isolated lung in such a way that blood 
from the host rat was withdrawn by a constant hydro- 
static pressure of 20 mm Hg from the right internal 
jugular vein to perfuse the pulmonary artery of the 
isolated lung. A Transonic flow probe (Transonic Sys- 
tems, Inc., Ithaca, N.Y.) was incorporated into the 
perfusion line for flow measurements. The isolated lung 
was suspended in a perfusion chamber, which was 
immersed in a 37 ° C water bath. Blood returned from 
the isolated lung was collected in the perfusion cham- 
ber. A roller pump returned the blood from the perfu- 
sion chamber to the left carotid artery of the host rat. 
The rate of blood returning to the host rat was adjusted 
to maintain satisfactory systemic pressure (Fig. 1). 
During the perfusion period, the isolated lung was 
ventilated with room air at respiratory rate of 40 to 50 
rpm, tidal volume of 2.5 ml, and peak end-expiratory 
pressure of 0.5 cm H20. 
After an initial 5- to 10-minute quilibration period, 
blood samples from the pulmonary artery and vein were 
taken simultaneously every 10 minutes for blood gas 
analysis and alveolar-arterial oxygen difference calcula- 
tion with the IL BGE Blood Gas and Electrolytes Ana- 
lyzer (Instrumentation Laboratories, Lexington, Mass.). 
Perfusion pressure, perfusion flow, airway pressure, and 
tidal volume were recorded continuously on a Gould 
multichannel recorder (Gould Inc, Centerville, Ohio). 
Using these parameters, we calculated pulmonary vascu- 
lar resistance and airway resistance. At the end of the 
experiment, lung tissue samples were taken for wet/dry 
weight ratio measurements. 
Animal groups studied. Twenty-four rats were used in 
this study. The rats were divided into three groups. Group 
1 rats (n = 8) were used as normal controls. The left lungs 
were removed and immediately transferred to the perfu- 
sion apparatus for function studies. In this group, no 
interruption of ventilation occurred, and interruption of 
lung perfusion was routinely less than 10 to 20 seconds. 
Lung function i  this group was assumed to be normal. In 
group 2 (n = 8), the left lungs were flushed with 10 to 15 
ml of 4 ° C Euro-Collins olution at a gravity gradient of 20 
cm H20 and immersed in 4 ° C Euro-Collins solution for 
24 hours. In group 3 (n = 8), the left lungs were also 
flushed with 10 to 15 ml of 4 ° C Euro-Collins solution, 
followed by 5 ml of 4 ° C saline solution containing 
DADLE (1 mg/kg, Peninsula Lab, Belmont, Calif.) and 
then immersed in 4 ° C Euro-Collins and DADLE solution 
for 24 hours. In groups 2 and 3, the bronchus was clamped 
at the end of inspiration to keep the lung inflated during 
storage. 
Statistieal analysis. Two-way analysis of variance was 
used for repeated measurements. If significance was es- 
tablished, the Student-Newman-Keuls test was used to 
analyze the difference between individual groups. A value 
of p < 0.05 was considered significant. All results were 
expressed as means _+ standard error of the mean. 
Results 
Severe pulmonary edema and hemorrhage oc- 
curred in group 2 (Euro-Col l ins solution alone) 
within 30 minutes of perfusion, and no preparat ion 
could be perfused for more than 30 minutes because 
of occlusive pulmonary resistance. This phenome-  
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Fig. 1. Apparatus for isolated lung perfusion study. Venous blood from the host rat is used to perfuse the 
lung. Blood returned from the lung is infused into the carotid artery of the host rat. PA, Pulmonary artery; 
PV, pulmonary vein; C, perfusion chamber, R, reservoir. 
non did not occur in either group 1 (control) or 
group 3 (Euro-Collins plus DADLE), where perfu- 
sion studies could be carried out for more than 60 
minutes in these two groups. Oxygen tension and 
carbon dioxide tension in the pulmonary artery and 
vein of the isolated tung during the 60-minute 
reperfusion period remained stable and were com- 
parable between groups 1 and 3. Pulmonary vascular 
resistance and airway resistance were also stable 
during the perfusion period in these two groups. 
Blood flow and pulmonary vascular resistance of 
the isolated lung. Pulmonary blood flow ranged 
from 2.06 + 0.25 to 3.50 + 0.56 ml/min in group 1, 
from 0.65 ± 0.10 to 0.87 ± 0.10 ml/min in group 2, 
and from 1.68 ± 0.09 to 1.94 ± 0.21 tal/min in group 
3. Pulmonap• blood flow was lower in group 2 than 
in either group 1 or group 3. In group 1, pulmonary 
vascular esistance ranged from 7.96 ± 0.76 to 14.00 
+_ 2.60 mm Hg/tal/min; in group 2, it ranged from 
33.00 ± 5.00 to 50.50 ± 11.00 mm Hg/ml/min (p < 
0.05 as compared with group 1 and 3); and in group 
3, it ranged from 13.60 ± 1.00 to 15.00 ± 1.00 mm 
Hg/tal/min. Because of high pulmonary vascular 
resistance in group 2, perfusion could not be con- 
tinued after 30 minutes, indicating severe tissue 
edema and damage in this group. No difference was 
found in pulmonary vascular resistance between 
group 1 and group 3 (Fig. 2). 
Airway pressure and resistance of the isolated 
lung. When tidal volume 2.5 ml was used, airway 
pressure ranged from 6.4 ± 0.4 to 9.3 ± 1.2 mm Hg 
in group 1, from 13.9 ± 0.9 to 17.6 _+ 1.2 mm Hg in 
group 2, and from 9.3 ± 0.8 to 13.3 ± 1.2 mm Hg in 
group 3. Airway pressure was rauch higher in Group 
2 (p < 0.05 as eompared with group 1 and group 3). 
It was also higher after 20 minutes of perfusion in 
group 3 than in group 1 (p < 0.05). 
Airway resistance ranged from 2.6 +_ 0.2 to 3.4 ± 
0.4 mm Hg/tal in group 1, from 5.5 ± 0.3 to 7.0 ± 0.4 
mm Hg/tal in group 2, and from 3.8 ± 0.4 to 5.0 _+ 
0.5 mm Hg/tal in group 3. Airway resistance was 
rauch higher in group 2 than in groups 1 and 3 ~ < 
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Fig. 3. Comparison of airway resistance in the three groups. 
0.05). However, airway resistance was also higher in 
group 3 than in group 1 after 20 minutes of perfu- 
sion (p < 0.05, Fig. 3). 
Blood gases in the inflow and outflow of the iso- 
lated lung. Mean oxygen tension in the pulmonary 
artery (before oxygenation) was 33 _+ 1.6 to 36 _+ 2.1 
mm Hg in group 1, 48 ± 5 to 52 ± 7 mm Hg in group 
2, and 53 ± 4.0 to 60 ± 3.7 mm Hg in group 3. Mean 
oxygen tensions from the pulmonary vein (after 
oxygenation by the isolated lung) were 130 + 13 to 
180 + 11 mm Hg in group 1, 70 -+ 9.0 to 92 ___ 14 mm 
Hg in group 2, and 116 + 8.0 to 173 ± 21 mm Hg in 
group 3. Oxygen tensions in group 2 were lower than 
in groups 1 and 3 during perfusion and worsened 
when perfusion time was longer, indicating impaired 
oxygenation capacity in this group (Fig. 4). 
The Journa[ of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 1 
Wu et al. 263 
Fig. 4. 
200 
150 
"I" 
E g 
Z 
O 
09 100 
Z 
LU 
I,-'- 
Z 
U.I 
(5 
>" 50 
X 
O 
T 
T -- ---)  . 
Group 2 
* p<0.01 Group 2 vs .  Groups 1 and 3 
I L F I I I i 
10 20 30 40 50 60 
Group 1 
Group 3 
PERFUSION TIME (min) 
Comparison of oxygen tensions in the isolated pulmonary vein in the three groups. 
Carbon dioxide tension in the pulmonary artery 
was 30 _+ 2.7 to 38 +_ 2 mm Hg in group 1, 41 ~_ 4 to 
41 + 7 mm Hg in group 2, and 16 +_ 2 to 23 _+ 3 mm 
Hg in group 3. Carbon dioxide tension in the 
pulmonary vein was 17 +_ 0.6 to 19 _+ 2.0 mm Hg in 
group 1, 17 +_ 2.5 to 23 _+ 4 mm Hg in group 2, and 
16 + 2 to23 + 3 mm Hg in group 3. No statistically 
significant difference was found among the three 
groups, a!though perfusion time was much shorter 
in group 2. 
Alveolar-arterial oxygen differenee. Alveolar-ar- 
terial oxygen difference ranged from 4.68 +_ 4.62 to 
30.29 _+ 10.28 mm Hg in group 1, from 44.01 + 10.94 
to 54.88 _+ 6.16 mm Hg in group 2, and from 0.46 + 
0.46 to 23.49 _+ 5.45 mm Hg in group 3. Alveolar- 
arterial oxygen differenee was rauch higher in group 
2 than either group 1 or group 3 (p < 0.05, Fig. 5). 
Lung tissue wet/dry weight ratio after perfusion. 
Lung tissue wet/dry weight ratio after perfusion was 
6.3 _+ 0.4 in group 1, 8.7 + 0.5 in group 2, and 5.7 _+ 
0.7 in group 3. Tissue wet/dry weight ratio was much 
higher in group 2 than in groups 1 and 3 (p = 0.005), 
even though the perfusion time was only 30 minutes 
in group 2. No difference was found in tissue wet/dry 
ratio between group 1 and group 3 (Fig. 6). 
Discussion 
The scareity of suitable donor organs is the main 
limitation to transplantation. Among all the organs, 
the lung is probably the most difficult o preserve for 
several reasons: (1) the unique, delicate architeeture 
of the lung poses a special problem in preservation; 
methods allowing short-term storage of the kidney, 
liver, and heart have not been successful for lungs; 
(2) efforts to extend the ischemic period by cooling 
the lungs with cold gas ventilation, perfusion, or 
flushing have been ineffective, producing edema in 
preserved lungs; (3) as with the heart, total func- 
tional dependence is required of the preserved lung 
after it is transplanted, making the functional viabil- 
ity of tissue critical during a preservation period. 4
Single-flush perfusion of the lungs is currently the 
most widely practiced technique in lung preserva- 
tion. However, when simple flushing with various 
preservation solutions is performed, the results have 
generally been unsatisfactory, with only a few ex- 
ceptions. 5-7 For years, numerous chemicals and 
modifications, such as prostaglandins, s'9 oxygen 
free-radical scavengers, 1°'11 platelet-activating fac- 
tor antagonists or leukocyte depletion, 12' 13 cortico- 
steroids, 14 and other chemicals, 15-17 have been added 
to pulmonary flush solutions (e.g., modified Euro- 
Collins solution, University of Wisconsin solution, 
University of California-Los Angeles solution, Stan- 
ford solution, low potassium dextran solution, and 
Bretschneider's solution). Although various reports 
have indicated that such chemicals provide im- 
proved effects, of which prostaglandins are an excel- 
lent example, no additive has shown consistently 
reliable results. 1s-22 Our results from group 2 ani- 
mals appear to agree with those of previous reports; 
that is, when preservation time exceeds 6hours, lung 
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function is severely damaged, as indicated by re- 
duced perfusion flow, increased perfusion pressure, 
decreased oxygen tension in the pulmonary vein, 
and increased lung tissue water content. Euro- 
Collins solution alone is known to cause pulmonary 
vasoconstriction. Although the other aforemen- 
tioned solutions have been used by many centers in 
both animal and human models, no solution has 
been shown to be physiologically successful for safe 
human lung preservation beyond 6 hours. 19' 23-26 
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Fig. 7. Effect of DADLE on arterial blood pressure in an anesthetized dog. 
Previous smdies from our laboratory have shown 
that DADLE can effectively extend tissue survival 
time in a normothermic multiorgan preservation 
block. The mechanism by which DADLE extends 
tissue survival time in normothermic tissue preser- 
vation appears to be its ability to protect issue from 
damage during various ischemic insults. The possi- 
ble mechanisms that might be responsible for tissue 
protection are as follows: (1) reducing tissue metab- 
olism during ischemia; (2) reducing or eliminating 
liver congestion; (3) improving tissue perfusion; and 
(4) reducmg platelet/leukocyte aggregation. 1'27 Of 
these properties, the elimination of liver congestion 
and the reduction of platelet/leukocyte aggregation 
can only be seen during normothermic perfusion. 
However, if DADLE can reduce tissue metabolism 
or improve tissue perfusion, it would also protect 
tissue from ischemic damage during hypothermia. If 
this is the case, the potential use of this chemical will 
be tremendous. Not only will it improve organ 
preservation by adding positive effects to presently 
used preservation solutions, but it will also enhance 
the effectiveness of various currently used cardiople- 
gic solutions and possibly that of other hypothermic 
treatment modalities. 
Our results indicate that, when DADLE was 
added to ithe Euro-Collins solution, lungs that had 
been preseP~ed for 24 hours maintained excellent 
function, a result that has not been achieved in 
previous reports that used Euro-Collins solution 
alone. The most noteworthy findings in these studies 
were the near-normal tissue wet/dry weight ratio 
along with near normal pulmonary blood flow, pul- 
monary vascular resistance, and good oxygen-ex- 
changing capacity in the lungs after 24 hours of 
preservation. In comparison with normal lungs 
(without preservation), airway resistance in the 
lungs preserved with DADLE increased only slightly 
after preservation. The resistance was much lower 
than that measured in lungs preserved with Euro- 
Collins solution alone. 
Because of the complexity of opioids and their 
receptors, studies to date have primarily concen- 
trated on the reactions of different opioids with 
different receptors. The effects of opioids on the 
cardiovascular system have been studied for many 
years, and the results are controversial.28,29 
Through a MEDLINE search, we found no reports 
that related opioid agonists to tissue metabolism or 
organ preservation other than those that have been 
published from our laboratory. ~'27 On the other 
hand, opioid antagonists, such as naloxone and 
nalmefene, have been reported to have a tissue 
protective ffect on liver, kidney, and intestine dur- 
ing ischemic insult. This effect is believed to be 
related to the ability of opioid antagonists to scav- 
enge superoxide. 3°-32 
Several possibilities exist for the protective ffect 
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of opioid agonists uch as DADLE on tissue damage 
from ischemia. The most intriguing of these possi- 
bilities relates to a reduction in tissue metabolism. 
Previous studies have indicated that delta opioid 
receptors may be responsible for naturally occurring 
animal hibernation. However, not all the opioid 
subtypes are involved in hibernation. Infusing mor- 
phine, a /x opioid agonist, into summer-active 
ground squirrels caused an insignificant bout of 
hibernation of extremely short duration. Similar 
results of short bouts of hibernation have been 
obtained with another peptidic /x opioid, morphi- 
ceptin, a naturally occurring k peptide of brain 
origin, dynorphin A, and a highly selective synthetic 
k opioid, U69593. On the other hand, animals 
receiving implanted pumps containing DADLE be- 
gan hibernating shortly after implantation and infu- 
sion. Continuous subcutaneous administration of 
naloxone, an opioid antagonist, diminished the fre- 
quency and length of hibernation bouts in Citellus 
tridecemlineatus. 33'34 These results strongly sug- 
gested that the/x opioid receptor and its ligand are 
intimately involved in the induction of animal hiber- 
nation, and animal hibernation may be induced by a 
mechanism involving an endogenous opioid that 
acts through binding to receptor sitesY Thus, it is 
possible that DADLE protects tissue from various 
types of damage during ischemia by a mechanism 
similar to animal hibernation. Inhibition of tissue 
metabolism or improvement of microcirculation by 
means of vasodilation probably plays an important 
role in this protection. We have shown, in previous 
experiments, a severe reduction of arterial blood 
pressure after intravenous injection of DADLE into 
anesthetized animals (Fig. 7). We have not yet 
performed systemic toxicity tests for DADLE. How- 
ever, in our multiorgan preservation studies we did 
not find a toxic effect on any major organ. ~ 
Evaluation of lung function after preservation has 
been hampered by the lack of a reliable testing 
model. In this study, the viability of the lungs was 
tested by means of a living rat perfusion model. 
Venous blood from the host rat perfused the iso- 
lated lung. Blood returned from the isolated lung 
was pumped back into the arterial system of the 
host. This route reduced the load on the host heart, 
and the aggregates and particles returned from the 
isolated lung were filtered by the host's peripheral 
microvasculature. In this setting, we were able to use 
orte host rat for two to three isolated lung studies 
totaling five or more hours of perfusion. This model 
has proved to be simple and stable, yet sensitive for 
testing isolated lung function. Although it is not 
always advisable to extrapolate experimental results 
from tests on small animals to large animals or to 
human beings, such animal experimentation pro- 
vides an effective and economical way to screen 
drugs and solutions for hypothermic lung preserva- 
tion. 
In summary, the present study clearly shows, for 
the first time, that DADLE has a positive effect on 
hypothermic preservation of rat lungs. This effect is 
related to the ability of DADLE to protect tissue 
from various forms of damage during ischemia. The 
exact mechanism of this effect is not clear and 
deserves further study. 
We thank Flo Witte for her editorial assistance. 
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